[Molecular pathobiology in heart failure]
- PMID: 7848657
[Molecular pathobiology in heart failure]
Erratum in
- Rev Port Cardiol 1995 Feb;14(2):179
Abstract
Heart failure is a pathophysiological state resulting from disturbed cardiac function. It is based on complex molecular processes, many of which are not fully understood. During heart failure adaptive mechanisms, that reinstall altered cardiac function, are activated. The main mechanisms are: a) Alteration of the structure and composition of myocytes by myocardial hypertrophy, reexpression of fetal and neo-natal proteins and the expression of certain proto-oncogenes; b) Activation of the neuroendocrinal system, specifically the sympathetic nervous system, renin-angiotensin-aldosterone system and vasopressin release; c) Activation of autocrine and paracrine systems. However, when these systems are activated beyond a certain limit they contribute to heart failure aggravation. This can also be promoted by alteration of the calcium metabolism inherent in heart failure. The synthesis of the counterregulator atrial natriuretic factor is also increased.
Similar articles
-
[Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].G Ital Cardiol. 1993 Feb;23(2):193-204. G Ital Cardiol. 1993. PMID: 8098306 Review. Italian.
-
Recognized molecular mechanisms of heart failure: approaches to treatment.Rev Port Cardiol. 1998 Oct;17 Suppl 2:II79-91. Rev Port Cardiol. 1998. PMID: 9835784 Review.
-
[Neurohormonal activity in heart insufficiency].Ugeskr Laeger. 1993 Jun 7;155(23):1784-8. Ugeskr Laeger. 1993. PMID: 8317027 Danish.
-
[Neurohumoral regulation in heart failure].Z Kardiol. 1996;85 Suppl 6:205-10. Z Kardiol. 1996. PMID: 9064967 Review. German.
-
[Neuroendocrine activation in heart failure I. Pathophysiology and pharmacological intervention].Ugeskr Laeger. 2000 Oct 30;162(44):5905-9. Ugeskr Laeger. 2000. PMID: 11094549 Review. Danish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical